If you're a patient of Javier Hernandez, M.D., and a MyChart user, you can:
Dr. Javier Hernandez currently serves as an assistant professor in the department of urology at UT Health San Antonio. In addition to his clinical duties, he is actively involved in various research endeavors on the early detection of prostate cancer. He has an interest in all aspects of general urology as well as a particular interest in the prevention, diagnosis and treatment of urologic malignancies including tumors of the kidney, bladder, prostate, testis and male genitalia.
Dr. Hernandez also has particular expertise in retroperitoneal lymph node dissections for the management of metastatic testicular cancer. He covers clinical duties at various institutions to include the UT Health Physicians Ambulatory Surgery Center, University Hospital, CHRISTUS Santa Rosa Northwest Hospital and the Audie L. Murphy Memorial Veterans Hospital.
Ankerst, D. P., Hoefler, J., Bock, S., Goodman, P. J., Vickers, A., Hernandez, J., Sokoll, L. J., Sanda, M. G., Wei, J. T., Leach, R. J. & Thompson, I. M. Prostate Cancer Prevention Trial Risk Calculator 2.0 for the Prediction of Low- vs High-grade Prostate Cancer. Urology 83, 1362-1368 (2014). PMID: 24862395; PMCID: PMC4035700
Gelfond, J., Choate, K., Ankerst, D. P., Hernandez, J., Leach, R. J. & Thompson, I. M.,Jr. Intermediate-term Risk of Prostate Cancer is Directly Related to Baseline PSA: Implications for Reducing the Burden of PSA Screening. J. Urol. 194(1):46-51 (2015). PMID: 25686543
Overholser, S., Nielsen, M., Torkko, K., Cwilka, D., Weaver, B., Shi, X., Leach, R. J., Hernandez, J., Huang, T., Thompson, I. M., Jr & Thompson, I. M.,3rd. Active Surveillance is An Appropriate Management Strategy for A Proportion of Men Diagnosed With Prostate Cancer by PSA Testing. J. Urol. 194(3):680-4 (2015). PMID: 25636657
Population Science and Prevention ProgramDr. Javier Hernandez's research profile